throbber
Paper: 10
`Date: October 30, 2015
`
`
`
`
`
`
`Trials@uspto.gov
`571-272-7822
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`WOCKHARDT BIO AG,
`Petitioner,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC.,
`Patent Owner.
`____________
`
`Case IPR2015-01814
`Patent 8,457,988 B1
`____________
`
`
`
`
`
`Before JACQUELINE WRIGHT BONILLA, SUSAN L. C. MITCHELL, and
`BRIAN P. MURPHY, Administrative Patent Judges.
`
`
`
`
`
`
`MURPHY, Administrative Patent Judge.
`
`DECISION
`Institution of Inter Partes Review and Grant of Motion for Joinder
`37 C.F.R. § 42.108; 37 C.F.R. § 42.122(b)
`
`
`
`

`
`IPR2015-01814
`Patent 8,457,988 B1
`
`
`I.
`
`INTRODUCTION
`
`Petitioner Wockhardt Bio AG (“Wockhardt”) filed a Petition requesting
`
`inter partes review of claims 1–15 of U.S. Patent No. 8,457,988 B1 (“the ’988
`
`patent”). Paper 1 (“Petition” or “Pet.”). The Petition was accorded a filing date of
`
`August 27, 2015. Paper 5. Wockhardt also filed a Motion for Joinder pursuant to
`
`35 U.S.C. § 315(c) requesting joinder of the present proceeding with Par Pharm.,
`
`Inc. v. Jazz Pharms., Inc., Case IPR2015-00551. Paper 4 (“Mot.”). IPR2015-
`
`00551 also concerns claims 1–15 of the ’988 patent owned by Jazz
`
`Pharmaceuticals, Inc. (“Patent Owner”). We instituted trial in IPR2015-00551 on
`
`July 28, 2015, on the grounds of (i) obviousness of claims 1, 3–9, and 11–15 over
`
`the same “Advisory Committee Art” (Exs. 1003–1006) relied upon by Wockhardt
`
`in the instant Petition, and (ii) obviousness of claims 2 and 10 over the Advisory
`
`Committee Art and “Korfhage” (Ex. 1037), also relied upon by Wockhardt in the
`
`instant Petition. IPR2015-00551, Paper 19. Wockhardt’s assertions of
`
`obviousness of claims 1–15 over the Advisory Committee Art and Korfhage in the
`
`Petition are the only grounds on which Wockhardt seeks institution of inter partes
`
`review. Pet. 11–12. Wockhardt filed the Petition and Motion for Joinder in the
`
`present proceeding on August 27, 2015, within one month after we instituted trial
`
`in IPR2015-00551. 37 C.F.R. § 42.122(b).
`
`II. DISCUSSION
`
`Based on authority delegated to us by the Director, we have discretion to
`
`join an inter partes review to a previously instituted inter partes review. 35 U.S.C.
`
`§ 315. Section 315(c) provides, in relevant part, that “[i]f the Director institutes an
`
`inter partes review, the Director, in his or her discretion, may join as a party to that
`
`inter partes review any person who properly files a petition under section 311.” Id.
`
`When determining whether to grant a motion for joinder we consider factors such
`
`
`
`2
`
`

`
`IPR2015-01814
`Patent 8,457,988 B1
`
`as timing and impact of joinder on the trial schedule, cost, discovery, and potential
`
`simplification of briefing. Kyocera Corp. v. SoftView, LLC, Case IPR2013-00004,
`
`slip op. at 4 (PTAB Apr. 24, 2013) (Paper 15).
`
`We convened a conference call on September 14, 2015, among counsel for
`
`Wockhardt, Amneal Pharmaceuticals (“Amneal”),1 Par Pharmaceutical, Inc.
`
`(“Par”), and Patent Owner. The subject of the conference call was a discussion of
`
`the conditions proposed by Wockhardt in its Motion for Joinder, requesting that we
`
`join the present proceeding with IPR2015-00551. We refer to the transcript of the
`
`conference call filed by counsel for Wockhardt for the details of the call and
`
`representations and agreements made by the parties. Ex. 1033.
`
`Of particular relevance, we note that Wockhardt’s Petition is based only on
`
`the identical grounds on which we instituted inter partes review in IPR2015-
`
`00551. Mot. 5. The Petition is based on “the same arguments, evidence, and
`
`ground of unpatentability” and is otherwise “identical to the instituted Par IPR
`
`Petition.” Id.; Ex. 1033, 7:2–18. We further note that Wockhardt agreed to, inter
`
`alia, (i) “adopt any papers submitted by Par in the joined IPR proceeding . . .
`
`including the testimony from the same expert witness(es) as in the instituted trial;”
`
`(ii) “not seek to submit any new expert declarations from those entered by Par,
`
`except to the extent that . . . Wockhardt is precluded from relying on Par’s experts’
`
`declarations, e.g., if Par settles with Jazz and contractually bind its experts from
`
`continuing in the IPR with Wockhardt;” (iii) “not seek additional time at any
`
`deposition and that Par will be permitted to ask questions before Wockhardt;” and
`
`(iv) “not seek any additional time at any oral argument.” Mot. 8–10. Patent
`
`
`1 Amneal is a petitioner in a series of related inter partes review proceedings
`(IPR2015-00545, IPR2015-00546, IPR2015-00547, and IPR2015-00554) also
`involving petitioner Par and Patent Owner Jazz Pharmaceuticals, Inc.
`
`
`
`3
`
`

`
`IPR2015-01814
`Patent 8,457,988 B1
`
`Owner agreed that, if joinder were to be ordered on the conditions set forth in the
`
`Motion for Joinder, then Patent Owner would not oppose joinder and would waive
`
`filing a preliminary response to the Petition. Ex. 1033, 7:20–9:13. The parties also
`
`agreed that the schedule in IPR2015-00551 would remain in place without
`
`requiring any extensions of time. Id. at 6:11–22, 8:8–12, 28:11–21.
`
`At the conclusion of the conference call, we asked counsel for Wockhardt,
`
`Amneal, and Par to attempt to reach agreement on any remaining issues among
`
`them regarding joinder and to inform the Board no later than Friday September 18,
`
`2015, whether agreement was reached, and whether any of the parties intended to
`
`file an opposition to Wockhardt’s Motion for Joinder by September 25, 2015. Ex.
`
`1033, 34:12–35:14.
`
`On September 18, 2015, we received an email from counsel for Wockhardt,
`
`on which counsel for Amneal, Par, and Patent Owner were copied, indicating there
`
`was agreement among Wockhardt, Amneal, and Par, and that none of the parties
`
`would oppose the Motion for Joinder based on the conditions proposed in
`
`Wockhardt’s Motion, as clarified and agreed during the conference call. In view of
`
`the foregoing, we find that joinder based upon the conditions stated by Wockhardt
`
`in its Motion for Joinder will have little or no impact on the timing, cost, or
`
`presentation of the trial on the instituted grounds. Discovery and briefing will be
`
`simplified if the two proceedings are joined. Therefore, there being no opposition
`
`to Wockhardt’s Motion for Joinder from any of the parties, the Motion for Joinder
`
`is granted.
`
`
`
`
`
`4
`
`

`
`IPR2015-01814
`Patent 8,457,988 B1
`
`
`Accordingly, it is
`
`III.
`
` ORDER
`
`ORDERED that trial is instituted in IPR2015-001814 as to the obviousness
`
`of (i) claims 1, 3–9, and 11–15 of the ’988 patent over the Advisory Committee
`
`Art, and (ii) claims 2 and 10 of the ’988 patent over the Advisory Committee Art
`
`and Korfhage, the same grounds on which we instituted trial in IPR2015-00551;
`
`FURTHER ORDERED that Wockhardt’s Motion for Joinder with IPR2015-
`
`00551 is granted;
`
`FURTHER ORDERED that IPR2015-01814 is terminated and joined to
`
`IPR2015-00551, pursuant to 37 C.F.R. §§ 42.72, 42.122, based on the conditions
`
`stated in Wockhardt’s Motion for Joinder (Paper 4) as clarified and agreed during
`
`the conference call of September 14, 2015 (Ex. 1033);
`
`FURTHER ORDERED that the Scheduling Order in place for IPR2015-
`
`00551 shall govern the joined proceedings;
`
`FURTHER ORDERED that all future filings in the joined proceeding are to
`
`be made only in IPR2015-00551;
`
`FURTHER ORDERED that the case caption in IPR2015-00551 for all
`
`further submissions shall be changed to add Wockhardt as a named petitioner after
`
`Par, and to indicate by footnote the joinder of IPR2015-01814 to that proceeding,
`
`as indicated in the attached form of caption; and
`
`FURTHER ORDERED that a copy of this Decision shall be entered into the
`
`record of IPR2015-00551.
`
`
`
`
`
`5
`
`

`
`IPR2015-01814
`Patent 8,457,988 B1
`
`FOR PETITIONER:
`
`Laura Vogel
`Patrick Gallagher
`LAVogel@duanemorris.com
`PCGallagher@duanemorris.com
`
`
`
`FOR PATENT OWNER:
`
`F. Dominic Cerrito
`Evangeline Shih
`Frank C. Calvosa
`Eric C. Stops
`nickcerrito@quinnemanuel.com
`evangelineshih@quinnemanuel.com
`frankcalvosa@quinnemanuel.com
`ericstops@quinnemanuel.com
`
`John V. Biernacki
`jvbiernacki@jonesday.com
`
`
`
`FOR PAR PHARMACEUTICAL, INC. (IPR2015-00551):
`
`Aziz Burgy
`Bradford C. Frese
`Aziz.Burgy@arentfox.com
`Bradford.Frese@arentfox.com
`
`
`
`6
`
`
`
`
`
`
`
`

`
`IPR2015-00551
`Patent 8,457,988 B1
`
`Sample Case Caption
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`PAR PHARMACEUTICAL, INC. and WOCKHARDT BIO AG,
`Petitioners,
`
`v.
`
`JAZZ PHARMACEUTICALS, INC.,
`Patent Owner.
`____________
`
`Case IPR2015-005511
`Patent 8,457,988 B1
`____________
`
`
`
`
`
`
`
`
`
`1 Case IPR2015-01814 has been joined with this proceeding.

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket